Skip to main content
. 2021 Feb 26;13(3):764. doi: 10.3390/nu13030764

Table 4.

Mean fat oxidation measures at baseline (week 0), week 4 and 8 between intervention groups.

PL dGTE dGTE+
Variable Baseline Week 4 Week 8 Baseline Week 4 Week 8 Baseline Week 4 Week 8
MFO (mg·min−1) 228.1 ± 23.4 219.5 ± 34.1 201.1 ± 25.2 199.0 ± 30.8 223.2 ± 32.3 224.4 ± 27.8 154.4 ± 20.6 176.6 ± 19.3 224.6 ± 23.2 *
MFO·FFM−1 (mg·min−1) 4.7 ± 0.7 4.1 ± 0.6 3.7 ± 0.5 4.0 ± 0.6 4.4 ± 0.6 4.5 ± 0.5 3.2 ± 0.4 3.7 ± 0.4 4.7 ± 0.5 *
FATMAX (% V.O2peak) 35.2 ± 2.0 38.6 ± 2.2 38.0 ± 1.9 36.5 ± 6.0 34.1 ± 1.8 36.5 ± 2.9 39.5 ± 2.6 34.4 ± 1.3 42.7 ± 2.3
HR at FATMAX (%HRmax) 57.6 ± 1.9 58.5 ± 2.1 57.7 ± 1.7 56.3 ± 1.5 57.9 ± 1.6 56.8 ± 1.7 57.1 ± 1.7 57.5 ± 2.1 58.1 ± 1.6
FATMIN (% V.O2peak) 61.7 ± 4.3 64.7 ± 4.2 56.1 ± 4.0 60.1 ± 4.1 54.9 ± 3.4 57.2 ± 3.6 58.3 ± 2.6 55.1 ± 1.9 67.6 ± 3.6 #

PL = placebo; dGTE = decaffeinated green tea extract; dGTE+ = decaffeinated green tea extract with antioxidants. MFO = maximal fat oxidation rate; MFO·FFM−1 = relative maximal fat oxidation rate (per kg FFM); FATMAX= exercise intensity at which MFO occurs; FATMAX HR = heart rate at MFO expressed relative to maximum HR; FATMIN = exercise intensity where FATOX deemed zero. * significantly different from baseline within group (p ≤ 0.024); # significantly different to week 4 within group (p = 0.003).